These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 35787838)

  • 1. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis.
    Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK
    J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
    Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase separation and other forms of α-Synuclein self-assemblies.
    Poudyal M; Sakunthala A; Mukherjee S; Gadhe L; Maji SK
    Essays Biochem; 2022 Dec; 66(7):987-1000. PubMed ID: 36373662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation and phase separation of α-synuclein in Parkinson's disease.
    Han W; Wei M; Xu F; Niu Z
    Chem Commun (Camb); 2024 Jun; 60(52):6581-6590. PubMed ID: 38808534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese promotes α-synuclein amyloid aggregation through the induction of protein phase transition.
    Xu B; Huang S; Liu Y; Wan C; Gu Y; Wang D; Yu H
    J Biol Chem; 2022 Jan; 298(1):101469. PubMed ID: 34871547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium promotes α-synuclein liquid-liquid phase separation to accelerate amyloid aggregation.
    Huang S; Xu B; Liu Y
    Biochem Biophys Res Commun; 2022 May; 603():13-20. PubMed ID: 35276458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myricetin Inhibits α-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition.
    Xu B; Mo X; Chen J; Yu H; Liu Y
    Chembiochem; 2022 Aug; 23(16):e202200216. PubMed ID: 35657723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein.
    Leitão ADG; Rudolffi-Soto P; Chappard A; Bhumkar A; Lau D; Hunter DJB; Gambin Y; Sierecki E
    Commun Biol; 2021 Sep; 4(1):1124. PubMed ID: 34556785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating α-Synuclein Liquid-Liquid Phase Separation.
    Sawner AS; Ray S; Yadav P; Mukherjee S; Panigrahi R; Poudyal M; Patel K; Ghosh D; Kummerant E; Kumar A; Riek R; Maji SK
    Biochemistry; 2021 Dec; 60(48):3676-3696. PubMed ID: 34431665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
    Kalsoom I; Wang Y; Li B; Wen H
    Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein aggregation nucleates through liquid-liquid phase separation.
    Ray S; Singh N; Kumar R; Patel K; Pandey S; Datta D; Mahato J; Panigrahi R; Navalkar A; Mehra S; Gadhe L; Chatterjee D; Sawner AS; Maiti S; Bhatia S; Gerez JA; Chowdhury A; Kumar A; Padinhateeri R; Riek R; Krishnamoorthy G; Maji SK
    Nat Chem; 2020 Aug; 12(8):705-716. PubMed ID: 32514159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The disordered protein SERF promotes α-Synuclein aggregation through liquid-liquid phase separation.
    Liu HN; Wang T; Hu JJ; Chen L; Shi X; Li YM; Luo SZ
    J Biol Chem; 2024 Mar; 300(3):105667. PubMed ID: 38272228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis.
    Gadhe L; Sakunthala A; Mukherjee S; Gahlot N; Bera R; Sawner AS; Kadu P; Maji SK
    Biophys Chem; 2022 Feb; 281():106736. PubMed ID: 34923391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
    Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
    J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease.
    Negi S; Khurana N; Duggal N
    Neurochem Int; 2024 Jul; 177():105760. PubMed ID: 38723900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein phase separation and amyloid aggregation are modulated by C-terminal truncations.
    Huang S; Mo X; Wang J; Ye X; Yu H; Liu Y
    FEBS Lett; 2022 Jun; 596(11):1388-1400. PubMed ID: 35485974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
    Wang R; Sun H; Ren H; Wang G
    Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.